isoniazid has been researched along with Benign Neoplasms in 77 studies
Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).
| Excerpt | Relevance | Reference |
|---|---|---|
| "41 226 isoniazid exposed and 22 811 non-exposed patients admitted to Canadian institutions for the treatment of tuberculosis from 1952 to 1960 were followed to 1973 by computerised record linkage to the National Death Index and, for 1969 to 1973, to the National Cancer Incidence Reporting System; The mortality for the total cohort compared to that expected from the mortality in the Canadian population, was greater than expected for tuberculosis, other chest diseases and certain cancer sites associated with cigarette smoking (except bladder cancer)." | 7.66 | Isoniazid exposure in relation to cancer incidence and mortality in a cohort of tuberculosis patients. ( Coppock, E; Howe, GR; Lindsay, J; Miller, AB, 1979) |
| " The development of isoniazid for the prevention of tuberculosis is reviewed." | 3.68 | Prevention of infections in patients with neoplastic disease: use of a historical model for developmental strategies. ( White, MH, 1993) |
| "41 226 isoniazid exposed and 22 811 non-exposed patients admitted to Canadian institutions for the treatment of tuberculosis from 1952 to 1960 were followed to 1973 by computerised record linkage to the National Death Index and, for 1969 to 1973, to the National Cancer Incidence Reporting System; The mortality for the total cohort compared to that expected from the mortality in the Canadian population, was greater than expected for tuberculosis, other chest diseases and certain cancer sites associated with cigarette smoking (except bladder cancer)." | 3.66 | Isoniazid exposure in relation to cancer incidence and mortality in a cohort of tuberculosis patients. ( Coppock, E; Howe, GR; Lindsay, J; Miller, AB, 1979) |
| "Ever since the discovery of cancer stem cells (CSCs), they have progressively attracted more attention as a therapeutic target." | 3.01 | Extirpating the cancer stem cell hydra: Differentiation therapy and Hyperthermia therapy for targeting the cancer stem cell hierarchy. ( Saini, A; Sharma, D; Tewari, AB, 2023) |
| "No trend toward an increasing cancer rate in the isoniazid group was observed with the passage of time." | 2.65 | The incidence of cancer among participants in controlled, randomized isoniazid preventive therapy trial. ( Costello, HD; Snider, DE, 1980) |
| "However, how cancer patterns in humans compare to those of other species remains largely unknown." | 2.58 | From humans to hydra: patterns of cancer across the tree of life. ( Albuquerque, TAF; de Magalhães, JP; Doherty, A; Drummond do Val, L, 2018) |
| "The association of latent tuberculosis infection (LTBI) with subsequent cancer remains unclear." | 1.43 | Latent Tuberculosis Infection and the Risk of Subsequent Cancer. ( Chen, TJ; Chen, YM; Chou, KT; Chuang, PH; Feng, JY; Pan, SW; Su, VY; Su, WJ; Yen, YF, 2016) |
| "Infection in cancer patients with TB was significantly more often recorded among elderly patients and those suffering from poverty." | 1.38 | Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence, risk factors and resistance pattern. ( Afifi, S; Eissa, S; El-Dahshan, R; El-Sharif, A; Rafeh, N, 2012) |
| "Suramin was used to analyze the growth-effects of blockade of iron uptake on two established human cell lines, U-937 (monocytoid) and K-562 (erythroleukemic)." | 1.27 | Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH). ( Bjelkenkrantz, K; Forsbeck, K; Nilsson, K, 1986) |
| "Thymidine deficiency has been reported to increase DNA replication errors and hence increase mutagenesis." | 1.27 | Theoretical involvement of vitamin B6 in tumour initiation. ( Prior, FG, 1985) |
| "National Cancer Institute and two Federal Agencies, seven drugs were listed." | 1.26 | Epidemiological studies of medically used drugs. ( Clemmesen, J; Hjalgrim-Jensen, S, 1980) |
| "Increased deaths from liver cirrhosis (5 vs 0." | 1.26 | Late effects following isoniazid therapy. ( Boice, JD; Fraumeni, JF, 1980) |
| "The mothers of children who developed cancer reported about 25% more illnesses during pregnancy than mothers of healthy control children." | 1.26 | Childhood cancer and drugs in pregnancy. ( Draper, GJ; Sanders, BM, 1979) |
| " The relative risks of death from all malignant neoplasms for patients receiving a total dosage of less than 50, 50-99, 100-199 and 200 g or more were 1." | 1.26 | An assessment of the carcinogenicity of isoniazid in patients with pulmonary tuberculosis. ( Fox, W; Peto, J; Stephens, R; Stott, H, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (75.32) | 18.7374 |
| 1990's | 4 (5.19) | 18.2507 |
| 2000's | 1 (1.30) | 29.6817 |
| 2010's | 8 (10.39) | 24.3611 |
| 2020's | 6 (7.79) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Leitao, RCF | 2 |
| Silva, F | 2 |
| Ribeiro, GH | 2 |
| Santos, IC | 2 |
| Guerreiro, JF | 2 |
| Mendes, F | 2 |
| Batista, AA | 2 |
| Pavan, FR | 2 |
| da S Maia, PI | 2 |
| Paulo, A | 2 |
| Deflon, VM | 2 |
| Belay, M | 1 |
| Tulu, B | 1 |
| Younis, S | 1 |
| Jolliffe, DA | 1 |
| Tayachew, D | 1 |
| Manwandu, H | 1 |
| Abozen, T | 1 |
| Tirfie, EA | 1 |
| Tegegn, M | 1 |
| Zewude, A | 1 |
| Forrest, S | 1 |
| Mayito, J | 1 |
| Huggett, JF | 1 |
| Jones, GM | 1 |
| O'Sullivan, DM | 1 |
| Martineau, HM | 1 |
| Noursadeghi, M | 1 |
| Chandran, A | 1 |
| Harris, KA | 1 |
| Nikolayevskyy, V | 1 |
| Demaret, J | 1 |
| Berg, S | 1 |
| Vordermeier, M | 1 |
| Balcha, TT | 1 |
| Aseffa, A | 1 |
| Ameni, G | 1 |
| Abebe, M | 1 |
| Reece, ST | 1 |
| Martineau, AR | 1 |
| Mollan, KR | 1 |
| Eron, JJ | 1 |
| Krajewski, TJ | 1 |
| Painter, W | 1 |
| Duke, ER | 1 |
| Morse, CG | 1 |
| Goecker, EA | 1 |
| Premkumar, L | 1 |
| Wolfe, CR | 1 |
| Szewczyk, LJ | 1 |
| Alabanza, PL | 1 |
| Loftis, AJ | 1 |
| Degli-Angeli, EJ | 1 |
| Brown, AJ | 1 |
| Dragavon, JA | 1 |
| Won, JJ | 1 |
| Keys, J | 1 |
| Hudgens, MG | 1 |
| Fang, L | 1 |
| Wohl, DA | 1 |
| Cohen, MS | 1 |
| Baric, RS | 1 |
| Coombs, RW | 1 |
| Sheahan, TP | 1 |
| Fischer, WA | 1 |
| Li, B | 1 |
| Wang, X | 1 |
| Hong, S | 1 |
| Wang, Q | 1 |
| Li, L | 1 |
| Eltayeb, O | 1 |
| Dong, C | 1 |
| Shuang, S | 1 |
| Liao, X | 1 |
| Lu, J | 1 |
| Ying, P | 1 |
| Zhao, P | 1 |
| Bai, Y | 1 |
| Li, W | 1 |
| Liu, M | 1 |
| Moussa, RS | 1 |
| Kovacevic, Z | 2 |
| Richardson, DR | 5 |
| Su, VY | 1 |
| Yen, YF | 1 |
| Pan, SW | 1 |
| Chuang, PH | 1 |
| Feng, JY | 1 |
| Chou, KT | 1 |
| Chen, YM | 1 |
| Chen, TJ | 1 |
| Su, WJ | 1 |
| Yu, Y | 1 |
| El-Sharif, A | 1 |
| Afifi, S | 1 |
| El-Dahshan, R | 1 |
| Rafeh, N | 1 |
| Eissa, S | 1 |
| FORNI, PV | 1 |
| LEIDER, M | 1 |
| SAWICKY, HH | 1 |
| BERENCSI, G | 1 |
| ENTZ, A | 1 |
| VAJKOCZY, A | 1 |
| POMPE, K | 1 |
| SKERIK, P | 1 |
| WOLFART, W | 1 |
| BALDINI, L | 2 |
| BRAMBILLA, G | 2 |
| WAGNER, H | 1 |
| MORITZ, R | 1 |
| JUHASZ, J | 2 |
| BALO, J | 3 |
| SZENDE, B | 2 |
| MATSUDA, M | 2 |
| SASA, M | 1 |
| SUGIYAMA, K | 1 |
| WALCZAK, H | 1 |
| KENDREY, G | 1 |
| COSSEL, L | 1 |
| PELUSO, E | 1 |
| TRENCSENI, T | 1 |
| SZILVESZTROV, V | 1 |
| GVALJA, I | 1 |
| BIANCIFIORI, C | 1 |
| BUCCIARELLI, E | 1 |
| CLAYSON, DB | 2 |
| SANTILLI, FE | 1 |
| LOSCALZO, B | 1 |
| MICHALOWSKI, R | 1 |
| KUDEJKO, T | 1 |
| HATTORI, S | 1 |
| BONSER, GM | 2 |
| ROE, FJ | 1 |
| BOYLAND, E | 2 |
| HADDOW, A | 1 |
| Hammond, EC | 1 |
| Selikoff, IJ | 1 |
| Robitzek, EH | 1 |
| Schmähl, D | 2 |
| Habs, M | 1 |
| Clemmesen, J | 2 |
| Hjalgrim-Jensen, S | 2 |
| Costello, HD | 1 |
| Snider, DE | 2 |
| Boice, JD | 1 |
| Fraumeni, JF | 1 |
| Sinués, B | 1 |
| Rueda, P | 1 |
| Benítez, J | 1 |
| Saenz, MA | 1 |
| Bernal, ML | 1 |
| Lanuza, J | 1 |
| Alda, O | 1 |
| Tres, A | 1 |
| Bartolome, M | 1 |
| White, MH | 1 |
| Milnes, K | 1 |
| Glassroth, JL | 1 |
| White, MC | 1 |
| Sanders, BM | 1 |
| Draper, GJ | 1 |
| Howe, GR | 2 |
| Lindsay, J | 1 |
| Coppock, E | 1 |
| Miller, AB | 1 |
| Krauthammer, C | 1 |
| Klerman, GL | 1 |
| Stott, H | 1 |
| Peto, J | 1 |
| Stephens, R | 1 |
| Fox, W | 1 |
| Forsbeck, K | 1 |
| Bjelkenkrantz, K | 1 |
| Nilsson, K | 1 |
| Anderson, TW | 1 |
| Prior, FG | 1 |
| Lesobre, R | 1 |
| Ruffino, J | 1 |
| Tubiana, M | 1 |
| Thomas, PK | 1 |
| Hildebrand, J | 1 |
| Kenis, Y | 1 |
| Miller, CT | 1 |
| Sparks, FC | 1 |
| Silverstein, MJ | 1 |
| Hunt, JS | 1 |
| Haskell, CM | 1 |
| Pilch, YH | 1 |
| Morton, DL | 1 |
| Klastersky, J | 1 |
| Weerts, D | 1 |
| Hensgens, C | 1 |
| Debusscher, L | 1 |
| Ferebee, SH | 1 |
| Munn, A | 1 |
| Donaldson, RC | 1 |
| Nyfors, A | 1 |
| Cocchi, R | 1 |
| Cocchi Belisario, C | 1 |
| Rink, H | 1 |
| Boutry, J | 1 |
| Mistral, J | 1 |
| Berlioz, L | 1 |
| Klimovich, A | 3 |
| Tökölyi, J | 1 |
| Fontenille, L | 1 |
| Ujvari, B | 1 |
| Dujon, AM | 1 |
| Giraudeau, M | 1 |
| Thomas, F | 1 |
| Adashek, JJ | 1 |
| Subbiah, V | 1 |
| Westphalen, CB | 1 |
| Naing, A | 1 |
| Kato, S | 1 |
| Kurzrock, R | 1 |
| Tewari, AB | 1 |
| Saini, A | 1 |
| Sharma, D | 1 |
| Rathje, K | 1 |
| Mortzfeld, B | 1 |
| Hoeppner, MP | 1 |
| Taubenheim, J | 1 |
| Bosch, TCG | 1 |
| Albuquerque, TAF | 1 |
| Drummond do Val, L | 1 |
| Doherty, A | 1 |
| de Magalhães, JP | 1 |
| Domazet-Lošo, T | 1 |
| Anokhin, B | 1 |
| Anton-Erxleben, F | 1 |
| Hamm, MJ | 1 |
| Lange, C | 1 |
| Bosch, TC | 1 |
| Shostak, S | 1 |
10 reviews available for isoniazid and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Therapeutic potential of iron chelators in cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Deferoxamine; Humans; Iron; Iron Chelating Agents; Isoni | 2002 |
Analogues of pyridoxal isonicotinoyl hydrazone (PIH) as potential iron chelators for the treatment of neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Transport; Carrier Proteins; Cell Division; Humans; Iron | 1998 |
Peripheral neuropathy.
Topics: Arsenic Poisoning; Deficiency Diseases; Humans; Isoniazid; Lead Poisoning; Metabolic Diseases; Neopl | 1970 |
[Causal genesis of malignant tumors].
Topics: Animals; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carcinogens; Carcinoma, Squamous Cell; | 1973 |
The correlation of experimental carcinogenesis and cancer in man.
Topics: Alkylating Agents; Animals; Anthelmintics; Carcinogens; Environmental Exposure; Griseofulvin; Humans | 1969 |
Controlled chemoprophylaxis trials in tuberculosis. A general review.
Topics: Adolescent; Adult; Age Factors; Alaska; Anemia; Child; Child, Preschool; Clinical Trials as Topic; D | 1970 |
Cancer: slaying the nine-headed Hydra.
Topics: Animals; Humans; Hydra; Medical Oncology; Neoplasms | 2023 |
Extirpating the cancer stem cell hydra: Differentiation therapy and Hyperthermia therapy for targeting the cancer stem cell hierarchy.
Topics: Animals; Cell Differentiation; Humans; Hydra; Hyperthermia, Induced; Neoplasms; Neoplastic Stem Cell | 2023 |
From humans to hydra: patterns of cancer across the tree of life.
Topics: Animals; Biological Evolution; Genetic Predisposition to Disease; Humans; Hydra; Neoplasms; Species | 2018 |
6 trials available for isoniazid and Benign Neoplasms
| Article | Year |
|---|---|
The incidence of cancer among participants in controlled, randomized isoniazid preventive therapy trial.
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Female; Humans; Isoniazid; Male; Middle Ag | 1980 |
Isoniazid--an attempt at retrospective prediction. A report of an ad hoc expert groups of the International Commission for Protection Against Environmental Mutagens and Carcinogens.
Topics: Acetyltransferases; Biotransformation; Carcinogens; Chromosomes; Clinical Trials as Topic; Drug Eval | 1980 |
An assessment of the possible association of isoniazid with human cancer deaths.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Isoniazid; Mal | 1977 |
Isoniazid: epidemiological evidence.
Topics: Adult; Child; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Ison | 1985 |
[Isoniazid and carcinogenesis].
Topics: Adenoma; Adult; Animals; Carbamates; Carcinoma; Child; Clinical Trials as Topic; Female; Humans; Hyd | 1969 |
Controlled chemoprophylaxis trials in tuberculosis. A general review.
Topics: Adolescent; Adult; Age Factors; Alaska; Anemia; Child; Child, Preschool; Clinical Trials as Topic; D | 1970 |
62 other studies available for isoniazid and Benign Neoplasms
| Article | Year |
|---|---|
Gallium and indium complexes with isoniazid-derived ligands: Interaction with biomolecules and biological activity against cancer cells and Mycobacterium tuberculosis.
Topics: Antineoplastic Agents; Coordination Complexes; Gallium; Humans; Indium; Isoniazid; Ligands; Male; My | 2023 |
Gallium and indium complexes with isoniazid-derived ligands: Interaction with biomolecules and biological activity against cancer cells and Mycobacterium tuberculosis.
Topics: Antineoplastic Agents; Coordination Complexes; Gallium; Humans; Indium; Isoniazid; Ligands; Male; My | 2023 |
Gallium and indium complexes with isoniazid-derived ligands: Interaction with biomolecules and biological activity against cancer cells and Mycobacterium tuberculosis.
Topics: Antineoplastic Agents; Coordination Complexes; Gallium; Humans; Indium; Isoniazid; Ligands; Male; My | 2023 |
Gallium and indium complexes with isoniazid-derived ligands: Interaction with biomolecules and biological activity against cancer cells and Mycobacterium tuberculosis.
Topics: Antineoplastic Agents; Coordination Complexes; Gallium; Humans; Indium; Isoniazid; Ligands; Male; My | 2023 |
Topics: Cross-Sectional Studies; DNA; Ethiopia; HeLa Cells; HIV Infections; Humans; Hydrogen Peroxide; Isoni | 2021 |
DNA binding, antitumor activities, and hydroxyl radical scavenging properties of novel oxovanadium (IV) complexes with substituted isoniazid.
Topics: 2,2'-Dipyridyl; Animals; Antineoplastic Agents; Apoptosis; Cattle; Cell Cycle; Cell Line, Tumor; Coo | 2013 |
Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.
Topics: Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinas | 2015 |
Latent Tuberculosis Infection and the Risk of Subsequent Cancer.
Topics: Adult; Aged; Antitubercular Agents; Case-Control Studies; Female; Humans; Isoniazid; Latent Tubercul | 2016 |
Chelators to the rescue: different horses for different courses!
Topics: Aldehydes; Animals; Deferoxamine; Humans; Hydrazones; Iron Chelating Agents; Iron Overload; Isoniazi | 2011 |
Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence, risk factors and resistance pattern.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Bacteriological Techniques; Child; Drug Resistance, | 2012 |
[Isonicotinic acid hydrazide and neoplasia].
Topics: Animals; Isomerism; Isoniazid; Neoplasms; Neoplasms, Experimental; Niacin; Nicotinic Acids | 1952 |
Therapeutic assays of the Skin and Cancer Unit of the New York University Hospital. VIII. Isonicotinylhydrazine (rimifon) in the treatment of tuberculosis cutis, some other granulomatous processes and miscellaneous dermatoses of doubtful cause.
Topics: Hospitals, University; Isoniazid; Neoplasms; New York; Niacin; Nicotinic Acids; Skin Diseases; Tuber | 1953 |
[Isoniazid therapy and cancer of lungs].
Topics: Isomerism; Isoniazid; Lung Neoplasms; Neoplasms; Niacin; Nicotinic Acids | 1955 |
[Effects of isoniazid on pathogenesis of lupus carcinoma].
Topics: Carcinoma; Isomerism; Isoniazid; Lupus Vulgaris; Neoplasms; Niacin; Nicotinic Acids | 1956 |
[Isoniazid therapy of specific lymphomas of the throat].
Topics: Humans; Isoniazid; Lymphoma; Neck; Neoplasms; Pharynx; Staining and Labeling | 1959 |
[Does isonicotinic acid hydrazide induce tumors].
Topics: Carcinogens; Isoniazid; Neoplasms | 1960 |
[Antitumoral action of triethylene melamine-isonicotinic acid hydrazide association on Galliera sarcoma of the rat].
Topics: Animals; Isoniazid; Neoplasms; Rats; Sarcoma; Sarcoma, Experimental; Triethylenemelamine | 1959 |
[Inhibitory action of isonicotinic acid hydrazide on the development of Galliera sarcoma in the rat].
Topics: Animals; Isoniazid; Neoplasms; Rats; Sarcoma; Sarcoma, Experimental | 1959 |
[On alteration of the growth of Jensen sarcoma by roentgen irradiation in combination with INH].
Topics: Animals; Biological Phenomena; Isoniazid; Neoplasms; Physiological Phenomena; Radiation Effects; Sar | 1962 |
[New experimental data on the tumor-inducing effect of isonicotinic acid hydrazide (INH)].
Topics: Animals; Isoniazid; Leukemia; Leukemia, Experimental; Leukemia, Myeloid; Lymphoma; Lymphoma, Large B | 1963 |
[CASE OF PULMONARY TUBERCULOSIS MISDIAGNOSED AS LUNG METASTASIS OF MALIGNANT CHORIOCARCINOMA].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Choriocarcinoma; Diagnosis, Differ | 1963 |
[PULMONARY TUBERCULOSIS MISDIAGNOSED AS OTHER DISEASES].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Diagnosis, Differenti | 1963 |
[RECENT EXPERIMENTAL DATA ON CARCINOGENIC EFFECT OF ISONICOTINIC ACID HYDRAZIDE (INH)].
Topics: Carcinogens; Humans; Isoniazid; Leukemia; Leukemia, Myeloid; Lung Neoplasms; Lymphoma; Lymphoma, Lar | 1963 |
[ON THE TREATMENT OF DIFFERENT TYPES OF RHEUMATIC DISEASES IN PULMONARY TUBERCULOSIS AND LUNG TUMORS].
Topics: Agranulocytosis; Aminosalicylic Acid; Aminosalicylic Acids; Isoniazid; Leukopenia; Lung; Lung Neopla | 1964 |
[ON THE ELECTRON MICROSCOPIC STRUCTURE OF A NEW TRANSPLANTABLE MOUSE ASCITES SARCOMA INDUCED BY ISONICOTINIC ACID HYDRAZIDE (INH)].
Topics: Ascites; Carcinogens; Electrons; Humans; Isoniazid; Mice; Microscopy; Microscopy, Electron; Neoplasm | 1964 |
[THERAPEUTIC EFFECTS OF A METABOLITE OF PHENYLBUTAZONE (G 27202) IN PRIMARY SEROSITIS].
Topics: Aminopyrine; Blood Sedimentation; Humans; Isoniazid; Neoplasms; Oxyphenbutazone; Peritonitis; Perito | 1964 |
[PRIMARY FIBROSARCOMA OF THE CARDIAC VENTRICLE DIAGNOSED DURING LIFE].
Topics: Anti-Bacterial Agents; Blood Sedimentation; Diuretics; Electrocardiography; Fibrosarcoma; Heart Ausc | 1964 |
INDUCTION OF HEPATOMAS IN CBA-CB-SE MICE BY HYDRAZINE SULPHATE AND THE LACK OF EFFECT OF CROTON OIL ON TUMOUR INDUCTION IN BALB-C-CB-SE MICE.
Topics: Animals; Carcinoma, Hepatocellular; Croton Oil; Hydrazines; Isoniazid; Isonicotinic Acids; Liver; Li | 1964 |
[ISONICOTINIC ACID HYDRAZIDE AND NEOPLASMS].
Topics: Antineoplastic Agents; Isoniazid; Neoplasms; Neoplasms, Experimental; Pharmacology; Rats; Research | 1964 |
[CARCINOGENESIS IN LUPUS VULGARIS TREATED WITH VITAMIN D2 AND ISONICOTINIC ACID HYDRAZIDE].
Topics: Carcinogenesis; Carcinogens; Carcinoma; Ergocalciferols; Humans; Isoniazid; Lupus Vulgaris; Lymphati | 1965 |
[RELATIONSHIP BETWEEN CANCER AND TUBERCULOSIS. 2). A RETARDING EFFECT OF BCG INOCULATION FOR TUMOR INDUCTION IN MICE WITH INH OR URETHANE-4 NQO INJECTIONS].
Topics: Animals; Antitubercular Agents; BCG Vaccine; Isoniazid; Lung Neoplasms; Mice; Mycobacterium bovis; N | 1964 |
[CANCEROGENIC ACTIVITY OF VARIOUS THERAPEUTIC AGENTS].
Topics: Carcinogens; Drug Therapy; Humans; Iron; Isoniazid; Neoplasms; Thorium Dioxide; Urethane | 1964 |
CHEMOTHERAPY OF TUBERCULOSIS.
Topics: Carcinogens; Drug Therapy; Isoniazid; Lung Neoplasms; Mice; Neoplasms; Toxicology; Tuberculosis; Tub | 1965 |
CARCINOGENESIS OF ISONIAZID IN MICE.
Topics: Animals; Carcinogenesis; Carcinogens; Isoniazid; Mice; Neoplasms; Neoplasms, Experimental; Research; | 1965 |
Isoniazid and cancer.
Topics: Adult; Animals; Carcinogens; Child; Female; Humans; Isoniazid; Lung Neoplasms; Male; Mice; Neoplasms | 1967 |
Isoniazid therapy in relation to later occurrence of cancer in adults and in infants.
Topics: Adult; Aged; Aging; Carcinogens; Child; Child, Preschool; Female; Fetal Death; Fetal Diseases; Human | 1967 |
Cancer hazards of the pharmacy.
Topics: Animals; Arsenic; Carcinogens; Estrogens; Griseofulvin; Humans; Hypoglycemic Agents; Isoniazid; Mice | 1967 |
Drug-induced cancer.
Topics: Analgesics; Anesthetics; Animals; Antineoplastic Agents; Arsenic; Griseofulvin; Histamine H1 Antagon | 1980 |
Epidemiological studies of medically used drugs.
Topics: 2-Naphthylamine; Brain Neoplasms; Epidemiologic Methods; Female; Humans; Isoniazid; Liver Neoplasms; | 1980 |
Late effects following isoniazid therapy.
Topics: Adolescent; Adult; Female; Follow-Up Studies; Humans; Isoniazid; Liver Cirrhosis; Neoplasms; Time Fa | 1980 |
Thioether excretion, urinary mutagenicity, and metabolic phenotype in smokers.
Topics: Acetylation; Adult; Biomarkers; Creatinine; Debrisoquin; Female; Genetic Predisposition to Disease; | 1994 |
Prevention of infections in patients with neoplastic disease: use of a historical model for developmental strategies.
Topics: Humans; Immunocompromised Host; Infection Control; Isoniazid; Models, Biological; Neoplasms; Tubercu | 1993 |
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
Topics: Antineoplastic Agents; Apoptosis; Benzaldehydes; Cell Cycle; Cell Division; Deferoxamine; DNA Fragme | 1997 |
Childhood cancer and drugs in pregnancy.
Topics: Adolescent; Adult; Child; Child, Preschool; Epilepsy; Female; Fetus; Humans; Infant; Infant, Newborn | 1979 |
Is isonicotinic acid hydrazide (INH) carcinogenic to man? A 24-year follow-up of 3371 tuberculosis cases.
Topics: Alcohol Drinking; Carcinogens; Denmark; Female; Follow-Up Studies; Humans; Isoniazid; Lung Neoplasms | 1979 |
Isoniazid exposure in relation to cancer incidence and mortality in a cohort of tuberculosis patients.
Topics: Adolescent; Adult; Canada; Carcinogens; Female; Follow-Up Studies; Humans; Isoniazid; Lung Neoplasms | 1979 |
[Carcinogenic properties of hydrazines].
Topics: Animals; Carcinogens; Cricetinae; Humans; Hydrazines; Isoniazid; Neoplasms; Rats | 1977 |
Secondary mania: manic syndromes associated with antecedent physical illness or drugs.
Topics: Adrenal Cortex Hormones; Adult; Bipolar Disorder; Bromides; Epilepsy, Temporal Lobe; Humans; Isoniaz | 1978 |
An assessment of the carcinogenicity of isoniazid in patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Animals; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Isoniaz | 1976 |
Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).
Topics: Cell Cycle; Cell Division; Cell Line; DNA; Humans; Intracellular Membranes; Iron; Iron Chelating Age | 1986 |
Theoretical involvement of vitamin B6 in tumour initiation.
Topics: DNA; DNA Repair; Estrogens; Female; Folic Acid Deficiency; Humans; Isoniazid; Neoplasms; Niacin; Thy | 1985 |
Use of computerized record linkage in follow-up studies of cancer epidemiology in Canada.
Topics: Breast Neoplasms; Canada; Computers; Fluoroscopy; Follow-Up Studies; Humans; Isoniazid; Lung Neoplas | 1985 |
Additive toxicity of vincristine and other drugs for the peripheral nervous system. Three case reports.
Topics: Adult; Asparaginase; Female; Humans; Isoniazid; Male; Middle Aged; Neoplasms; Peripheral Nerves; Per | 1971 |
Letter: Isoniazid and cancer risks.
Topics: Animals; Child; Child, Preschool; Humans; Isoniazid; Male; Neoplasms; Tuberculosis; Urinary Bladder | 1974 |
Complications of BCG immunotherapy in patients with cancer.
Topics: BCG Vaccine; Fever; Humans; Immunotherapy; Injections; Injections, Intradermal; Isoniazid; Jaundice; | 1973 |
Fever of unexplained origin in patients with cancer.
Topics: Bacterial Infections; Carbenicillin; Cephalothin; Endocarditis; Ethambutol; Female; Fever of Unknown | 1973 |
Extrapolation of experimental carcinogenicity to the reality of industrial exposure.
Topics: Animals; Carbon Tetrachloride; Carcinogens; Chemical Industry; Cyclamates; Drug Contamination; Envir | 1972 |
Methotrexate plus Bacillus Calmette-Guérin (BCG) and isoniazid in the treatment of cancer of the head and neck.
Topics: Adult; Aged; BCG Vaccine; Carcinoma, Squamous Cell; Cyclophosphamide; Head; Head and Neck Neoplasms; | 1972 |
Lupus vulgaris, isoniazid, and cancer. The frequency of cancer deaths in 245 isoniazid-treated lupus vulgaris patients with an average observation period of 12 years.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Female; Hum | 1968 |
[A clinical study of the oncogenic properties of isoniazid and its derivatives].
Topics: Animals; Humans; Isoniazid; Neoplasms; Neoplasms, Experimental; Tuberculosis, Meningeal | 1967 |
[On the present status of chemotherapy of lung tuberculosis, especially in ambulatory use].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Child; Child, Preschool; Ethionamide; Female; Humans; Infa | 1967 |
Tumors (re)shape biotic interactions within ecosystems: Experimental evidence from the freshwater cnidarian Hydra.
Topics: Animals; Cnidaria; Ecosystem; Fresh Water; Hydra; Neoplasms | 2022 |
Dynamic interactions within the host-associated microbiota cause tumor formation in the basal metazoan Hydra.
Topics: Animals; Carcinogenesis; Hydra; Leptospiraceae; Microbiota; Neoplasms; Pseudomonas | 2020 |
Naturally occurring tumours in the basal metazoan Hydra.
Topics: Animals; Biological Evolution; Eukaryota; Female; Hydra; Male; Neoplasms; Vertebrates | 2014 |
Vegetative reproduction by budding in Hydria: a perspective on tumors.
Topics: Animals; Cell Differentiation; Cell Division; Colchicine; Hydra; Models, Biological; Morphogenesis; | 1977 |